medigraphic.com
ISSN 1561-302X (Print)

2014, Number 2

<< Back Next >>

Rev cubana med 2014; 53 (2)

Global cardiovascular risk in hypertensive elderly patients

Arias MA, García HRA, Oliva PM

Language: Spanish
References: 21
Page: 178-188
PDF size: 266.65 Kb.


ABSTRACT

Introduction: hypertension is the most common condition which can be prevented. Hypertension affect adult's health around the world.
Objective: to describe cardiovascular global risk in elderly hypertensive patients as well as the associated correlated risk factors.
Methods: an observational, transversal, descriptive study was conducted at the #2 general practice in Miraflores Nuevo from October 2009 to July 2010. A sample of 65 patients was constituted, who had a complete physical exam and a serum cholesterol dosification was used in each patients.
Results: the age rank 70-79 years (60 %), male gender (58.4 %) and diabetes mellitus (38.1 %) presented a strong association related to cardiovascular global risk. Systolic blood pressure ≥ 160 mmHg (30.7 %) and serum cholesterol levels ≥ 6.0 mmol/l (26.1 %) are related to a high class of cardiovascular global risk (p= 0.003 y p= 0.000). In women, diabetes mellitus (80.0 %) and systolic blood pressure ≥ 160 mmHg were the most common risk factors associated to a high class of global risk (p= 0.000 y p= 0.001 respectively), whereas in men these factors were systolic blood pressure (p= 0.000) and age ≥ 70 (p= 0.001).
Conclusions: in elderly hypertensive patients, diabetes mellitus systolic blood pressure ≥ 160 mmHg and age ≥ 70 were the more important risk conditions related to global cardiovascular risk.


REFERENCES

  1. Pérez CDM, Dueñas HA, Alfonzo GPJ, Vázquez VA, Navarro DD, Del Pozo JH et al. Guía cubana para la prevención, detección, diagnóstico y tratamiento del paciente hipertenso. La Habana: Ed. ECIMED; 2008.

  2. Anuario Estadístico de Cuba. Dirección Nacional de Estadísticas de Salud. MINSAP, 2009 [citado 18 nov 2013]. Disponible en: http://www.sld.cu/servicios/estadisticas/

  3. Agabiti-Rosei E, Giovanni S. Arterial Hypertension and Cardiac Damage: diagnostic and therapeutic guidelines presented by the Joint Committee of the Italian Society of Hypertension (SIIA), Italian Society of Cardiology (SIC), Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). High Blood Pressure & Cardiovascular Prevention. 2008;15(3):141-70.

  4. Haider AW, Larson MG, Franklin SS, Daniel L. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138(1):10-6.

  5. Levy D, Larson MG, Vasan RS, William BK, Kalon KL. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557-62.

  6. Lenfant C, Roccella EJ. A call to action for more aggressive treatment of hypertension. J Hypertens. 1999;17(1):S3-7.

  7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo L Jr, et al. National Heart, Lung, Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-52.

  8. Barclay L. Stress Management, Lifestyle Modification Help Control Systolic Blood Pressure in Elderly Patiens. J Alternative Complementary Medicine. 2008;14(21):129-38.

  9. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJC, Van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997;349(9046):151-4.

  10. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31(3):780-6.

  11. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56(45):1683-9.

  12. Greenland P, Knoll MD, Stamler J, Neaton DJ, Dyer RA, Garside BD, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290(7):891-7.

  13. Whelton PK. Arterial Hypertensive Epidemiology. Lancet. 2006;25(5):65-70.

  14. Cordiés Jackson L, Vázquez Vigoa A, Cordiés Jackson MT. Hipertensión arterial en el anciano. Acta Méd. 1997;7(1):133-43.

  15. Goch AM, Banach DP, Mikhailidis J. Endothelial Dysfunction in patients with non-complicated and complicated hypertension. Clin Exp Hypert. 2009;31(1):20-3.

  16. Corbatón AA, Cuervo PR, Serrano RM. La diabetes mellitus tipo 2 como enfermedad cardiovascular. Rev Esp Cardiol. 2007;7(1):9-22.

  17. Navas MC, Lugo HL, Ortiz DS. Estudio descriptivo del programa de rehabilitación cardiaca de la Clínica Las Américas. Rev Colomb Cardiol. 2011;18(32):199-205.

  18. Staessen JA, Wang JG. Cardiovascular protection and blood pressure reduction: a meta-Analysis. Lancet. 2001;358(9290):1305-15.

  19. Brown WV. Cholesterol lowering in the atherosclerosis. Am J Cardiol. 2000;86(4):29-32.

  20. Boyero FI, Montesino DI, Rodríguez CBB, Martínez PR. La hipertensión arterial en el adulto mayor, una amenaza en la calidad de vida. Rev Ciencias Médicas de La Habana. 2009;15(2):15-23.

  21. Gifford RW. Mitos acerca de la Hipertensión en el anciano. Clin Med North Am. 2005;71(5):1059-70.




2020     |     www.medigraphic.com